Pharmaceutical Manufacturers
No Patient Left Behind ™
As the nation's largest privately-owned specialty pharmacy, Orsini's focus is on providing patients with empathetic and quality care throughout the course of treatment. We stand apart in our early, knowledgeable and experience-based engagement with pharmaceutical manufacturers as we collaborate on the successful commercialization of new drugs and the enhancement of already approved drug programs.
Our portfolio includes numerous successful limited-distribution and exclusive drug launches, many of which are for the treatment of rare orphan diseases. We specialize in managing complex drug programs and can deliver under aggressive implementation timelines.
Hear from the Orsini leadership team on what makes us a valued partner to both patients
and pharmaceutical manufacturers.
Our customized services for pharmaceutical manufacturers include:
Program Design Collaboration
Referral and Prescription Processing
Pharmacy and Medical Benefit Payor Access
Reimbursement Support
Co-pay and Foundation Assistance Support
Patient Education and Drug Counseling
Nurse Coordination and Management
Direct Delivery to Home or Site of Administration
Supply Chain Management
Quick Start Programs (Clinical, PAP, Bridge)
Private Label Programs
HUB and Data Services
Highly-Customizable Process Flows and Business Rules
Compounding Services
NO PATIENT LEFT BEHIND ™
Every patient has a story, and we take pride to ensure we discover any and all opportunities to allow a patient access to treatment. We are widely known for our success in overcoming many common and unique barriers to starting a patient on service.
Centers of Excellence
- Acid Sphingomyelinase Deficiency
- Alcohol Dependence
- Alzheimer's Disease
- Atypical Hemolytic Uremic Syndrome
- Cartilage Disorders
- CDKL5 Deficiency Disorder
- Ceroid lipofuscinosis 2
- Complex Partial Seizures
- Cryopyrin-Associated Periodic Syndromes (CAPS)
- Cystinuria
- Duchenne Muscular Dystrophy
- Deficiency of Interleukin-1 Receptor Antagonist (DIRA)
- Dystrophic Epidermolysis Bullosa (DEB)
- Fabry Disease
- Gaucher Disease Type 1
- Growth Hormone Deficiency
- Hemophilia B
- Hereditary Angioedema
- Hereditary ATTR amyloidosis (hATTR)
- Homozygous Familial Hypercholesterolemia (HoFH)
- Idiopathic Pulmonary Fibrosis
- Keratoconus
- Long-Chain Fatty Acid Oxidation Disorders
- Migraine
- Mucopolysaccharidoses
- Opioid Dependence
- Paroxysmal Nocturnal Hemoglobinuria
- Pompe Disease
- Primary Hyperoxaluria Type 1
- Recurrent Pericarditis
- Schizophrenia
- Spinal Muscular Atrophy
- Tardive Dyskinesia
- Tumor-induced Osteomalacia
- Type 1 Diabetes
- Venous Thromboembolism
- X-linked Hypophosphatemia